Pharmaceutical companies by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Takeda Pharmaceutical leads the 33 pharmaceutical companies ranked by P/E ratio, at 304, ahead of Merck & Co (139) and Ligand Pharmaceuticals (120). Figures as of 18 Nov 2026, 21:28 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
33
First
Takeda Pharmaceutical304
Median
40.1
Combined market value
SAR 18.98T
Countries
10
Not ranked
28no P/E ratio on file

Market values as of .

All countries
All sectors
Pharmaceuticals
SAR
Clear filters
Pharmaceutical companies by P/E ratio
#CompanyP/E ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Takeda PharmaceuticalTAK · Health Care304SAR 254.9BSAR 79.78 1.71% down 54% up Japan
2Merck & CoMRK · Health Care139SAR 1.27TSAR 516.81 3.90% down 51% up United States
3Ligand PharmaceuticalsLGND · Health Care120SAR 22.4BSAR 1,120.46 1.67% up 43% up United States
4TG TherapeuticsTGTX · Health Care98.7SAR 37.5BSAR 248.02 5.44% up 107% up United States
5Teva Pharmaceutical IndustriesTEVA · Health Care98.2SAR 184.8BSAR 158.40 0.92% down 74% up Israel
6Jazz PharmaceuticalsJAZZ · Health Care73.3SAR 59.7BSAR 929.39 2.93% up 37% up Ireland
7Kiniksa Pharmaceuticals InternationalKNSA · Health Care72.0SAR 28BSAR 356.53 0.06% down 126% up United Kingdom
8Amneal PharmaceuticalsAMRX · Health Care54.7SAR 28.6BSAR 82.07 3.60% up 83% up United States
9BeOne MedicinesONC · Health Care51.7SAR 172.9BSAR 1,513.90 2.34% down 17% up Switzerland
10Corcept TherapeuticsCORT · Health Care51.0SAR 27.8BSAR 254.28 3.25% down 8% down United States
11AbbVieABBV · Health Care49.1SAR 1.9TSAR 1,072.82 2.33% down 26% up United States
12Royalty PharmaRPRX · Health Care44.9SAR 148.1BSAR 257.58 0.01% down 78% up United States
13Eli LillyLLY · Health Care44.9SAR 4.62TSAR 5,186.70 2.32% down 35% up United States
14GenmabGMAB · Health Care43.6SAR 117.9BSAR 191.19 1.91% down 70% up Denmark
15Dr. Reddy's LaboratoriesRDY · Health Care41.6SAR 46.8BSAR 56.19 1.28% up 5% up India
16Johnson & JohnsonJNJ · Health Care41.4SAR 2.46TSAR 1,022.90 2.15% down 38% up United States
17PfizerPFE · Health Care40.1SAR 599.9BSAR 105.25 1.44% down 14% up United States
18Abbott LaboratoriesABT · Health Care39.0SAR 678.8BSAR 391.90 0.22% down 17% down United States
19Vertex PharmaceuticalsVRTX · Health Care34.5SAR 510.2BSAR 2,012.22 0.42% up 27% up United States
20NovartisNVS · Health Care29.6SAR 1.1TSAR 582.19 2.46% down 25% up Switzerland
21Protagonist TherapeuticsPTGX · Health Care26.9SAR 31.1BSAR 476.98 2.00% up 46% up United States
22AstraZenecaAZN · Health Care25.3SAR 1.04TSAR 670.53 1.93% down 2% up United Kingdom
23SanofiSNY · Health Care23.4SAR 424.4BSAR 176.75 0.86% down 4% down France
24United TherapeuticsUTHR · Health Care21.8SAR 92.2BSAR 2,165.60 1.16% down 23% up United States
25Regeneron PharmaceuticalsREGN · Health Care20.9SAR 366.9BSAR 3,546.68 1.28% down 36% up United States
26Ascendis PharmaASND · Health Care17.8SAR 66.5BSAR 1,014.01 0.32% down 28% up Denmark
27GSKGSK · Health Care16.9SAR 365.3BSAR 182.22 1.34% down 6% up United Kingdom
28ZoetisZTS · Health Care14.6SAR 130.4BSAR 320.97 2.50% up 29% down United States
29Bristol-Myers SquibbBMY · Health Care13.2SAR 456.7BSAR 223.41 2.92% down 34% up United States
30GrifolsGRFS · Health Care10.2SAR 21.6BSAR 31.77 1.85% down 1% up Spain
31Novo NordiskNVO · Health Care10.0SAR 651.9BSAR 147.90 3.12% down 17% down Denmark
32Alnylam PharmaceuticalsALNY · Health Care7.5SAR 75.1BSAR 560.40 4.54% down 66% down United States
33Edgewise TherapeuticsEWTX · Health Care4.9SAR 17BSAR 155.18 1.59% down 88% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 28 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which pharmaceutical companies rank first by P/E ratio?

Takeda Pharmaceutical (304), Merck & Co (139) and Ligand Pharmaceuticals (120) are the top three of the 33 pharmaceutical companies ranked by P/E ratio as of 18 Nov 2026, 21:28 UTC.

How many pharmaceutical companies are in this ranking?

33 are ranked by P/E ratio. 28 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these pharmaceutical companies worth together?

The 33 pharmaceutical companies ranked by P/E ratio have a combined market value of SAR 18.98T as of 18 Nov 2026, 21:28 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Pharmaceutical companies by P/E ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.